Thomas Starzl

University of Pittsburgh, Richard King Mellon Foundation Announce Transformative Gift, Partnership To Make Pittsburgh Region A National Leader In Life Sciences Manufacturing

Retrieved on: 
Wednesday, November 17, 2021
Patient, Richard King Mellon, University, Carnegie Mellon University, Foundation, Trustee, Technology, Industry, Hazelwood (Green Bay, Wisconsin), NIH, Monongahela River, University of Pittsburgh, Neural basis of synesthesia, National Kidney and Transplant Institute, Robotics, Health, Heinz Endowments, UPMC Hillman Cancer Center, Student, University of Pittsburgh School of Medicine, Michigan State University Honors College, Solution, Wall Street, Laboratory, Therapy, Physician, COVID-19, Reimann, Faculty, Financial endowment, Center, School, Research, China Center for Energy and Environmental Policy Research, Knowledge, BioForge, Thomas Starzl, Growth, Translation, UPMC, Hazelwood (Pittsburgh), Pharmaceutical industry, Medicine, Renewable energy, Industrial design

"I am grateful for this support and confident that we'll succeed together in strengthening Southwestern Pennsylvania's role as a leading life sciences destination."

Key Points: 
  • "I am grateful for this support and confident that we'll succeed together in strengthening Southwestern Pennsylvania's role as a leading life sciences destination."
  • Said Richard King Mellon Foundation Director Sam Reiman: "The Foundation is making a historic bet on Pittsburgh to lead nationally in the life sciences.
  • About the University of Pittsburgh: Founded in 1787, the University of Pittsburgh is an internationally renowned leader in health sciences learning and research.
  • About the Richard King Mellon Foundation: Founded in 1947, the Richard King Mellon Foundation is the largest foundation in Southwestern Pennsylvania, and one of the 50 largest in the world.

OmniLife and Starzl Network Solidify Strategic Partnership to Drive Innovation

Retrieved on: 
Tuesday, May 11, 2021
Hospitals, Health, Surgery, American people of German descent, Thomas Starzl, Organ transplantation, Transplant, University of Pittsburgh, Medicine, Scientists, Physicians

b'OmniLife is pleased to announce a strategic partnership with the Starzl Network led by UPMC Children\xe2\x80\x99s Hospital of Pittsburgh to drive innovation around transplant graft selection and acceptance, specifically with the goal of reducing pediatric waitlist mortality.\nOmniLife has been leading efforts to improve communication between all partners involved in the organ transplantation process with its novel technology since 2016.

Key Points: 
  • b'OmniLife is pleased to announce a strategic partnership with the Starzl Network led by UPMC Children\xe2\x80\x99s Hospital of Pittsburgh to drive innovation around transplant graft selection and acceptance, specifically with the goal of reducing pediatric waitlist mortality.\nOmniLife has been leading efforts to improve communication between all partners involved in the organ transplantation process with its novel technology since 2016.
  • Through multiple clinical partnerships and funding awarded from the NIH, the company delivers clinical decision support in the palm of a surgeon\xe2\x80\x99s hand to aid in organ selection for transplant.
  • A clinical feasibility trial involving two centers within the Starzl Network is underway through the end of 2021.\n\xe2\x80\x9cOmniLife is looking at a problem in the transplant realm that does not currently have a solution,\xe2\x80\x9d said Asad Zaman, Director, UPMC Children\xe2\x80\x99s.
  • The Starzl Network honors the life and legacy of Thomas E. Starzl, MD, PhD, recognized as the father of transplantation, and carries on his work of discovery and lifesaving innovation.